(Q77693342)

English

[Four new drugs for glaucoma: apraclonidine, brimonidine, dorzolamide and latanoprost]

scientific article published on 01 September 1998

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

9856229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

review article

1 reference

stated in

Europe PubMed Central

title

[Four new drugs for glaucoma: apraclonidine, brimonidine, dorzolamide and latanoprost] (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

9856229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856229%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

ChEBI release 2020-05-28

1 reference

Hoyng PF

1

1 reference

stated in

Europe PubMed Central

PubMed ID

9856229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

Rasker MT

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

9856229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

publication date

1 September 1998

1 reference

stated in

Europe PubMed Central

PubMed ID

9856229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

published in

Nederlands Tijdschrift voor Geneeskunde

1 reference

stated in

Europe PubMed Central

PubMed ID

9856229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

volume

142

1 reference

stated in

Europe PubMed Central

PubMed ID

9856229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

issue

39

1 reference

stated in

Europe PubMed Central

PubMed ID

9856229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

page(s)

2138-2141

1 reference

stated in

Europe PubMed Central

PubMed ID

9856229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856229%20AND%20SRC:MED&resulttype=core&format=json

retrieved

7 December 2019

Identifiers

PubMed ID

9856229

1 reference

stated in

Europe PubMed Central

PubMed ID

9856229

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9856229%20AND%20SRC:MED&resulttype=core&format=json

(Q77693342)

[Four new drugs for glaucoma: apraclonidine, brimonidine, dorzolamide and latanoprost]

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)